<DOC>
	<DOCNO>NCT00275561</DOCNO>
	<brief_summary>This randomize controlled trial swallow fluticasone vs. placebo eosinophilic esophagitis . Eosinophilic esophagitis inflammatory condition wall esophagus becomes fill large number eosinophil , type white blood cell . Patients condition difficulty swallow ( dysphagia ) solid food . Prior treatment patient biopsies esophagus take questionnaire regard symptom . Treatment give 6 week , biopsy take esophagus measure change tissue treatment . The primary endpoint improvement dysphagia measure validated Mayo Dysphagia Questionaire . Secondary outcomes include partial symptom response , histologic ( tissue ) response treatment .</brief_summary>
	<brief_title>Topical Steroid Treatment Eosinophilic Esophagitis</brief_title>
	<detailed_description>This double-blind randomized placebo control trial evaluate effect aerosolize fluticasone therapy symptomatic dysphagia histologic eosinophilia adult newly diagnose eosinophilic esophagitis ( EoE ) . Participants randomize receive aerosolize swallow fluticasone 880 mcg bid placebo inhaler swallow bid 6 week . Four mid esophageal biopsy obtain 10 cm squamo-columnar junction ; formalin-fixed stain hematoxylin eosin . All esophageal biopsy read score single expert gastrointestinal pathologist . The formalin-fixed paraffin-embedded esophageal biopsy retrieve underwent standard major basic protein ( MBP ) immunofluorescence stain . All special stain slide read score another pathologist . 24-hour urine collect free cortisol standard technique . The original endoscopy perform patient enrol trial standard clinical technique . The endoscopy post treatment do clinical research unit principal investigator . Patients keep compliance log review phone interview 2 4 week time end study evaluation . Ninety percent compliance require study inclusion . At end 6 week , 24-hour urine cortisol do , patient underwent repeat endoscopy still treatment . Mid-esophageal biopsy obtain evaluate eosinophil density mast cell degranulation . At visit patient return dysphagia side effect questionnaire .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>&gt; 20 eosinophil / hpf biopsy mid esophagus ( hpf = highpowered field ) Abnormal dysphagia questionnaire ( question 1a `` yes '' , question 1c &gt; `` moderate '' question 2 &gt; `` less week '' ) Mayo Dysphagia Questionnaire . Clinical evidence infectious process potentially contribute dysphagia ( e.g. , candidiasis , cytomegalovirus , herpes ) Systemic topical steroid therapy reason past 3 month Previous steroid treatment Eosinophilic Esophagitis Intolerance steroid therapy past Other cause dysphagia identify endoscopy ( e.g. , reflux esophagitis , stricture , web , ring , achalasia , esophageal neoplasm ) Dilatation esophagus time index endoscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Eosinophilic Esophagitis</keyword>
	<keyword>Fluticasone</keyword>
	<keyword>Dysphagia</keyword>
</DOC>